| Merck Serono | |
|---|---|
| EMD Serono | |
| Type | Stock corporation |
| Founded | 2007 |
| Location | Geneva, Switzerland (Headquarters) |
| Key people | Elmar Schnee CEO |
| Industry | Biotechnology / Pharmaceutical |
| Key Products | Rebif, Gonal-f, Luveris, Ovidrel/Ovitrelle, Serostim, Saizen, Zorbtive and Raptiva, Erbitux |
| Revenue | USD ~5 billion (projected) |
| Website | http://www.merckserono.ch/ |
Merck Serono (EMD Serono in the United States and Canada) is a pharmaceutical company headquartered in Geneva, Switzerland.[1] In September 2006, Merck KGaA announced its intent to purchase the majority of Serono shares from Ernesto Bertarelli and the Bertarelli family. The Merck-Serono merger was announced on September 21, 2006. Merck KGaA and Serono operated as distinct entities until at least January 2007. As of January 5, 2007, Merck held the majority shares of Serono. The new company is called Merck Serono International S.A.
Merck KGaA is a completely separate company from the US company Merck & Co.. Therefore, in the US & Canada, Merck Serono is known as EMD Serono, Inc.
Drugs they market include Erbitux, UFT, Rebif, Novantrone, Gonal, Ovidrel/Ovitrelle, Zorbtive, Luveris, Saizen, Serostim, Glucophage, Concor, Euthyrox and Raptiva.
Collaborative Research
In addition to internal research and development activities Merck Serono is also involved in publicly funded collaborative research projects, with other industrial and academic partners. One example in the area of non-clinical safety assessment is the InnoMed PredTox.[2][3] The company is expanding its activities in joint research projects within the framework of the Innovative Medicines Initiative of EFPIA and the European Commission.[4]
References
- ^ Background Info, www.merckserono.net
- ^ Mattes WB (2008), Public consortium efforts in toxicogenomics, Methods Mol Biol. 2008;460:221-38 [1]
- ^ "InnoMed PredTox Member Organizations". http://www.innomed-predtox.com/consortium/members/. Retrieved 2008-08-25.
- ^ Innovative Medicines Initiative. "IMI Call Topics 2008". IMI-GB-018v2-24042008-CallTopics.pdf. European Commission. http://imi.europa.eu/docs/calls01_en.zip. Retrieved 2008-08-25.
External links
Open source encyclopedia content modification information:
This page was last modified on 21 November 2009 at 01:53.
Authorship and Review
Open source encyclopedia content provided here is not reviewed directly by MedLibrary.org. Content is sourced directly from Wikipedia and is authored by an open community of volunteers. It is not produced by or in any way affiliated with MedLibrary.org.
Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Merck Serono", which is available in its original form here:
http://en.wikipedia.org/w/index.php?title=Merck_Serono
All material adapted used from Wikipedia is available under the terms of the GNU Free Documentation License. Wikipedia® itself is a registered trademark of the Wikimedia Foundation, Inc.